Director Business Development - Early Cancer Detection

Director of Business Development - Early Cancer Detection

About Natera Early Cancer Detection

Early Cancer Detection is Natera’s newest focused business unit. Over the last several years,

the team has rapidly developed an industry-leading technology platform, developed a robust

product and launched a wide-scale FDA enabling clinical study which is currently enrolling

patients. The next phase of the business will be a broad clinical launch.

We are seeking a Director of Business Development to join our team and help expand our

partnerships with study and supply partners; drive continued success with our clinical trials; and

work with internal and external teams to enable clinical launch . This leader will be responsible

for developing and executing agreements including, but not limited to, commercial

partnerships; licensing, and potential acquisition evaluation and execution.

POSITION SUMMARY:

The Director of Business Development will evaluate external growth opportunities and

represent Natera in negotiations with partners, customers, and suppliers. The person in this

role is a natural leader with strategic vision, inspiring energy, and attention to detail. He/she

will have deal-making experience from the life sciences industry, with superb analytic and

modeling capabilities, creativity in deal structuring, a no-nonsense approach to negotiations,

and a passion for delivering results.

PRIMARY RESPONSIBILITIES:

Partnership Development: Identify, evaluate, and execute strategic partnerships with suppliers,

clinical study partners and other external parties as required.

Deal Execution: Lead negotiations, structure agreements, and drive to closure in collaboration

with Legal, Finance, and executive leadership.

Market Development: Build a pipeline of opportunities by understanding evolving landscape

and technologies in Early Cancer Detection.

Cross-Functional Leadership: Work closely with R&D, Product, and Clinical Affairs to align

external opportunities with internal strategy and capabilities.

QUALIFICATIONS:

 Track record of leading and closing strategic collaboration and licensing agreements

 8–10+ years of business development, strategic partnerships, or corporate

development experience in biopharma, diagnostics, or life sciences necessary for the

role

 Demonstrated track record of structuring and closing deals in oncology, ideally in

diagnostics.

 Strong scientific and commercial understanding of oncology, immunology, or related

therapeutic areas necessary for the role.

 Exceptional relationship-building, negotiation, and communication skills.

 Bachelor’s in healthcare, life sciences, pharmacy or related field is required; PhD in

relevant field is a strong plus.

 Industry background in diagnostics, software, life sciences, or private equity/venture

capital. 3+ years’ experience in Corporate Business Development, investment banking

or management consulting

KNOWLEDGE, SKILLS, AND ABILITIES:

 Strong communication and leadership skills necessary to effectively lead diligence teams

and build credibility with the executive leadership of partners and collaborators

 Strong analytical ability, comfort with science and numbers.

 Strong attention to detail.

 Passion for changing medicine and delivering results; curiosity to continue to learn

about this rapidly evolving field

 Demonstrated ability to manage client relationships Strong relationship development,

communications and negotiations skills

Why Join Us?

This is a rare opportunity to drive the next Phase of Early Cancer Detection from the industry

leader in Diagnostics. At Natera, you’ll join a fast-moving, high-impact team that is pushing the

boundaries of what’s possible in healthcare innovation.